Become A Member

Muhammad Maqsood Zahid¹, Khalid Farouk³, Khaleel Ahmad², Liaquat Ali², Hafiz Muhammad Javed⁴ and Muhammad Afzal Ch⁴

ABSTRACT

Objective: To assess the amount of blood lost by BPH patients receiving holmium laser prostate enucleation (HoLEP) surgery vs transurethral prostate resection (TURP).

Study Design: Observational / experimental study.

Place and Duration of Study: This study was conducted at the Foundation University Medical College, Rawalpindi from June 2022 and November 2022.

Materials and Methods: Two groups of forty BPH patients each were prospectively divided into Groups I and Group II. Patients in group I underwent HoLEP, while those in group II underwent TURP. Hemoglobin (Hb) measurements were made before to surgery and on the first postoperative day to gauge blood loss.

Results: Forty patients from the HoLEP group I and TURP group II were considered in this study. The hemoglobin loss was 0.26 ± 0.05 in group I and 0.71 ± 0.124 in group II. Hemoglobin levels dropped substantially less in the group I than in the group II.

Conclusion: Hemoglobin (Hb) level dropped after prostate surgery was substantially less in HoLEP than in TURP. We come to the conclusion that HoLEP is a very effective with low complications operation in patients with prostate enlargement in light of the elevated risk of bleeding.

Key Words: benign prostatic hyperplasia; fibrinolysis; holmium laser enucleation of the prostate; thrombin generation; transurethral resection of the prostate

Citation of article: Zahid MM, Farouk K, Ahmad K, Ali L, Javed HM, Ch MA. Comparison of Blood Loss in Holmium Laser Enucleation of the Prostate (HoLEP) Versus Transurethral Resection of Prostate (TURP). Med Forum 2023;34(1):43-46.